SARS-CoV-2

Plant-based ionizers are surprisingly effective at removing aerosols and could play an important role in preventing COVID-19 transmission.

A multifaceted study by the Singapore 2019 Novel Coronavirus Outbreak Research team is filling in some of the gaps left in the urgent quest to understand COVID-19 infection.

A*STAR researchers have developed a point-of-care rapid antibody test kit that can detect antibodies produced in response to SARS-CoV-2 infection in just fifteen minutes.

By eliminating bottlenecks and automating manual processes, the RESOLUTE test kit and RAVE system co-developed by A*STAR scientists will help give COVID-19 testing a much-needed boost.

A*STAR researchers use digital drug simulators to predict the efficacies of repurposed antivirals for treating COVID-19.

This ‘smart mask’ designed by A*STAR researchers may reduce the risk of infection in healthcare workers by enabling remote, real-time monitoring of patients’ symptoms.

Serology testing may be fast and easy to perform, but there are still some limitations that need to be overcome, suggests Laurent Renia.

Antibodies that recognize the SARS-CoV-2 spike protein show potential for diagnosing COVID-19.

The presence of memory T cells in COVID-19-recovered patients hints at their importance in COVID-19 immunity.

Could there be a drug that can both treat and protect against COVID-19? The answer may be found in antibody drugs, a promising therapeutic modality against the coronavirus.

A new test manufactured by A*STAR’s Diagnostics Development Hub in partnership with Duke-NUS Medical School could reveal if an individual is likely immune to COVID-19.

Sebastian Maurer-Stroh shares how bioinformatics has enabled Singapore to respond quickly to COVID-19 and will continue to play an important role in ongoing surveillance.